Rational and design of the T-STORHM Study: A prospective randomized trial comparing fresh whole blood to blood components for acutely bleeding trauma patients

Transfus Clin Biol. 2019 Nov;26(4):198-201. doi: 10.1016/j.tracli.2019.09.004. Epub 2019 Oct 1.


Massive hemorrhage remains the main cause of preventable death in combat settings and is also the main cause of year loss in developing countries. The management of these patients relies on blood transfusion and surgery. Time is a key factor, related to survival. Recent events highlight the need to be more efficient in the transfusion supply during terror attacks or mass casualties in civilian settings. Blood components therapy with a 1:1:1 ratio is associated with a decrease of mortality but encounters many logistic issues in those circumstances. Whole blood provides in one bag all the blood components in physiologic proportions with minimal amount of additive solution. Whole blood has been implemented in military as well as civilian settings worldwide. However, direct comparisons with component therapy in prospective clinical trials are scarce. Here we present the rational and the design of the T-STORHM (Trauma-Sang TOtal dans les Hémorragies Massives) trial. This prospective randomized multicentric clinical trial will test low titer group O whole blood to components therapy in the in-hospital management of trauma patients with massive hemorrhage. Sample size calculation, primary and secondary endpoints as trial blood products preparations are discussed. The trial is expected to start in 2019 in 6 civilians and military trauma centers. The French Military Health Service is promoting the study in collaboration with the French transfusion public service (Établissementfrançaisdusang).

Keywords: Clinical trial; Essai clinique; Hémorragie massive; Low titer; Massive hemorrhage; Sang total; Titre faible; Trauma; Whole blood.

MeSH terms

  • ABO Blood-Group System
  • Blood Component Transfusion
  • Blood Transfusion
  • Endpoint Determination
  • Equivalence Trials as Topic*
  • France
  • Hemorrhage / etiology
  • Hemorrhage / mortality
  • Hemorrhage / therapy*
  • Hospitals, Military
  • Humans
  • Inpatients
  • Leukocyte Reduction Procedures
  • Multicenter Studies as Topic / methods*
  • Patient Selection
  • Prospective Studies
  • Randomized Controlled Trials as Topic / methods*
  • Research Design*
  • Shock, Hemorrhagic / etiology
  • Shock, Hemorrhagic / mortality
  • Shock, Hemorrhagic / therapy
  • Trauma Centers
  • Wounds and Injuries / complications


  • ABO Blood-Group System